Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx

NCT00064103 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

51

Enrollment

NIH

Sponsor class

Conditions

Lip and Oral Cavity Cancer
Oropharyngeal Cancer
Stage 0 Lip and Oral Cavity Cancer
Stage 0 Oropharyngeal Cancer
Tongue Cancer

Interventions

BIOLOGICAL: Ad5CMV-p53 gene
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)